News
News Releases
Proteros and Axcelead DDP Enter Strategic Collaboration to Enhance Discovery Capabilities
Proteros and Axcelead DDP Enter Strategic Collaboration to Enhance Discovery Capabilities Axcelead gains access to Proteros’ capabilities...
Nissan Chemical and Axcelead DDP Enter into License Agreement for DNA-Encoded Library (DEL)
Tokyo and Fujisawa, Japan – February 24, 2026 – Nissan Chemical Corporation (Headquarter: Tokyo, Japan;...
Axcelead DDP Signs an Agreement with Astellas for HT-ADMET Studies
Fujisawa, Japan, December 11, 2025 – Axcelead Drug Discovery Partners, Inc. (President & CEO: Kengo Okada, Ph.D.;...
Axcelead DDP Enters into Contract Research Agreement with RealizeEdge Partners for the Creation of Candidate Compounds Targeting Specific Proteins
Fujisawa, Japan, November 11, 2025 – Axcelead Drug Discovery Partners, Inc. (Head Office: Fujisawa City, Kanagawa Prefecture;...
xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery
Kyoto and Kanagawa, Japan, September 18, 2025 – xFOREST Therapeutics Co., Ltd. (“xFOREST”) and Axcelead Drug Discovery...